About Dr Vivek

Medical Oncology & Hematology

Dr. Vivek Belathur

MBBS, MD (Internal Medicine), DM (Medical Oncology)

Dr. Vivek Belathur is an experienced Medical Oncologist with over 15 years of expertise in the diagnosis and management of solid tumours, haematological malignancies and bone marrow transplantation. His approach combines advanced, evidence-based cancer treatment with compassionate and patient-centred care.

πŸ‘¨β€βš•οΈ
15+ Years of Expertise
πŸŽ“
DM Medical Oncology
🌍
Australia Oncology Fellowship
πŸ…
ESMO Certified

Education & Advanced Training

Specialised medical training in oncology and cancer care.

MBBS

Mysore Medical College

1994 – 1999

MD

Internal Medicine

Bangalore Medical College
2002 – 2005

DM

Medical Oncology

Kidwai Memorial Institute of Oncology
2010 – 2013

Fellowship

Medical Oncology

Australia

ESMO

Certified

European Society for Medical Oncology

BCCPM

Palliative Medicine

Basic Certificate Course

Areas of Expertise

Comprehensive expertise across medical oncology and haematological cancers.

πŸŽ—οΈBreast Cancer
🫁Lung Cancer
🧬Gastrointestinal Cancers
🩺Genitourinary Malignancies
🌸Gynecological Cancers
πŸŽ—οΈHead & Neck Cancers
🩸Hematological Malignancies
πŸ›‘οΈImmunotherapy
🎯Targeted Therapy
🧬Precision Oncology
πŸ’‰Chemotherapy
❀️Palliative Oncology Care

Academic & Research Contributions

πŸ“š Author of multiple publications in national and international peer-reviewed medical journals.
πŸ”¬ Research involving lymphoma, Hodgkin lymphoma, rare malignancies and viral associations in cancer.
🎀 Presented research papers and posters at major national medical and oncology conferences.
πŸŽ“ Actively involved in oncology education, academic research and professional development.

Clinical Trial Experience

Experience in international Phase III and Phase IV oncology trials.

Principal Investigator

Phase III and multicentric studies involving targeted therapies and biologics in metastatic colorectal cancer, head & neck cancers and non-small cell lung cancer.

Co-Investigator

International Phase III and Phase IV studies involving HER2-positive breast cancer, bevacizumab biosimilars, trastuzumab emtansine and EGFR-mutated lung cancers.

Professional Memberships

ISMPO Indian Society of Medical & Paediatric Oncology
ESMO European Society for Medical Oncology
ASCO American Society of Clinical Oncology

Awards & Achievements

πŸ†

Best Paper Award – 2004

Karnataka Association of Physicians Conference for the study β€œLipid Profile in Young Healthy Smokers.”

International Exposure

Participation in leading global oncology conferences and programmes.

Berlin, Germany Precision Meeting in Head & Neck Cancer
2016
Chicago, USA ASCO Annual Meeting
2015
Singapore Global Oncology Summit
2014
Singapore ESMO Preceptorship – Neuroendocrine Tumours
2012